Patent Assignment
Reel/Frame 021109/0817
Release of Security Interest
Recorded: 2008-06-18
Pages: 4
Assignor
OSPREY PHARMACEUTICALS LIMITED
Executed: 2008-05-20
Assignee
OSPREY PHARMACEUTICALS USA, INC.
425 CALIFORNIA STREET, SUITE 1300, SAN FRANCISCO, CALIFORNIA, 94104
Covered Properties
(5)
Methods and Compositions for Treating Secondary Tissue Damage and Other Inflammatory Conditions and Disorders
Patent:
7,157,418 →
Application:
09/360,242 →
Cytotoxic Conjugates Comprising a Chemokine Receptor Targeting Agent
Patent:
7,166,702 →
Application:
09/453,851 →
Nucleic Acid Molecules Encoding Cytotoxic Conjugates That Contain a Chemokine Receptor Targeting Agent
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
Application:
10/375,209 →
Publication:
US 2003/0215421
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
Application:
11/361,977 →
Publication:
US 2006/0198820
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 15, 2001
From: MCDONALD, JOHN R.; COGGINS, PHILIP J.
To: OSPREY PHARMACEUTICAS LIMITED
Reel/Frame 012072/0349 →
Assignment of Assignor's Interest
Mar 10, 2006
From: MCDONALD, JOHN R.; COGGINS, PHILIP J.
To: OSPREY PHARMACEUTICALS, LTD.
Reel/Frame 017331/0531 →
Assignment of Assignor's Interest
Apr 21, 2006
From: MCDONALD, JOHN R.; COGGINS, PHILIP J.
To: OSPREY PHARMACEUTICALS, LTD.
Reel/Frame 017520/0372 →
Security Agreement
Dec 22, 2006
From: OSPREY PHARMACEUTICALS LIMITED DBA PHARMACEUTIQUES OSPREY
To: MMV FINANCIAL INC.
Reel/Frame 018672/0325 →
Assignment of Assignor's Interest
Jun 18, 2008
From: OSPREY PHARMACEUTICALS LIMITED
To: OSPREY PHARMACEUITCALS USA, INC.
Reel/Frame 021109/0747 →
Corrective Assignment to Correct the Receiving Party Data; Assignee's Company Name Previously Recorded on Reel 021109 Frame 0747. Assignor(S) Hereby Confirms the Assignment of Assignors Interest (See Document for Details).
Jun 26, 2008
From: OSPREY PHARMACEUTICALS LIMITED
To: OSPREY PHARMACEUTICALS USA, INC.
Reel/Frame 021158/0177 →
Corrective Assignment to Correct the the Assignor's Company Name and the Assignee Previously Recorded on Reel 021109 Frame 0817. Assignor(S) Hereby Confirms the Correct Assignor Name Should Be Mmv Financial Inc. and the Correct Assignee Should Be Osprey Pharmaceuticals Limited.
Jan 29, 2010
From: MMV FINANCIAL INC.
To: OSPREY PHARMACEUTICALS LIMITED
Reel/Frame 023870/0437 →
Corrective Assignment to Correct the Assignor's and Assignee's Name Previously Recorded on Reel 021109 Frame 0817. Assignor(S) Hereby Confirms the Release by Secured Party (See Document for Details).
Feb 3, 2010
From: MMV FINANCIAL INC.
To: OSPREY PHARMACEUTICALS LIMITED
Reel/Frame 023892/0089 →
Release of Security Interest
Feb 24, 2026
From: CORNERSTONE COLLATERAL CORP.
To: REBOUND TECHNOLOGIES, INC.
Reel/Frame 073875/0793 →